A comprehensive review of the diagnosis and management of mitral paravalvular leakage

We thought that the mechanism of LMC occlusion in our case was due to non-atherosclerotic CE originated from prosthetic mitral valve because preoperative CA of patient

Exclusion criteria were as follows: having a bioprosthetic mitral valve or more than one prosthetic valve, patients who had their valve surgery in the past six months,

Transcatheter valve-in-valve versus redo surgical aortic valve re- placement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and

Three-dimensional color Doppler image of the prosthetic mitral valve replacement and a trivial paravalvular regurgitation through small dehiscence adjacent to the left atrial

We showed that (1) MVA (calculated by PHT and planimetry) was significantly higher in patients with SR than in patients with AF, (2) transmitral pressure gradient (maximal and

Our study on the importance of location of PVL during deci- sion for reoperation after mitral valve replacement showed that the time period between diagnosis and reoperation time was

The detailed transesopha- geal and real-time three-dimensional echocardiography demonstrated two side-by-side Amplatzer ductal occluder devices (Fig. 1) and con- firmed

(Ao-aorta). C) TOE reveals a completely disappearance of mitral regurgitation following Amplatzer occluder implantation (arrow) for PVL. D) 3D-TOE after successful deployment